Your search returned 8 studies. (Get alerts for new studies):
- Familial and Atypical Urothelial Cancer Registry
Conditions: Urothelial Cancer - Renal Pelvis Cancer - Ureter Cancer - Bladder Cancer
5 Locations available
- E7389 in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction
Conditions: Bladder Cancer - Transitional Cell Cancer of the Renal Pelvis and Ureter - Urethral Cancer
24 Locations available
- Gemcitabine Hydrochloride and Cisplatin With or Without Bevacizumab in Treating Patients With Advanced Urinary Tract Cancer
Conditions: Bladder Cancer - Prostate Cancer - Transitional Cell Cancer of the Renal Pelvis and Ureter - Urethral Cancer
496 Locations available
- A Study of ALT-801 in Combination With Cisplatin and Gemcitabine in Muscle Invasive or Metastatic Urothelial Cancer
Conditions: Transitional Cell Carcinoma of Bladder - Urethra Cancer - Ureter Cancer - Malignant Tumor of Renal Pelvis
6 Locations available
- Gemcitabine and Split-Dose Cisplatin Plus Everolimus (RAD001) in Patients With Advanced Solid Tumor Malignancies
Conditions: Bladder Cancer - Renal Pelvis Cancer - Ureter Cancer
1 Location available
- Veliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Urothelial, or Non-Small Cell Lung Cancer
Conditions: Bladder Cancer - Extrahepatic Bile Duct Cancer - Gallbladder Cancer - Liver Cancer - Lung Cancer - Pancreatic Cancer - Transitional Cell Cancer of the Renal Pelvis and Ureter
5 Locations available
- Gemcitabine, Cisplatin, and Lenalidomide for Bladder Cancer
Conditions: Ureteral Neoplasms - Urinary Bladder Neoplasms - Urethral Neoplasms
1 Location available
- Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors
Conditions: Urethral Neoplasms - Neoplasms, Urethral - Ureter Cancer - Cancer of the Urethra - Urethral Cancer
1 Location available
|